文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型经静脉膈神经起搏导管在机械通气患者中的膈肌激活

Diaphragm Activation in Ventilated Patients Using a Novel Transvenous Phrenic Nerve Pacing Catheter.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论首例人体系列显示,经静脉膈神经起搏导管可安全激活膈肌,并在22例起搏受试者中使呼吸机压力时间乘积降低9.9%–48.6%。

该首例人体病例系列在24例择期房间隔缺损修补术前镇静机械通气患者中,经左锁骨下静脉置入9.5-Fr、含19个电极的中央静脉导管至 superior vena cava,评估最长90分钟。23例完成全方案者中,左侧膈神经捕获22/23(96%),右侧20/23(87%);1例因先天性左侧上腔静脉阻碍右侧捕获。22例起搏受试者刺激辅助呼吸期间呼吸机压力时间乘积均显著降低(范围9.9%–48.6%,p<0.001),即刻及2周随访无不良事件。作者结论:临时导管膈肌起搏安全且有效辅助机械通气。

要点

  • 23例完成全方案者中,经静脉刺激左侧膈神经捕获22/23(96%),右侧捕获20/23(87%)。
  • 22例起搏受试者刺激辅助呼吸期间呼吸机压力时间乘积均显著降低,范围9.9%–48.6%(p<0.001)。
  • 1例因先天性左侧上腔静脉阻碍右侧捕获,1例因与装置无关的原因未能测试。
  • 即刻及2周随访均无不良事件。
  • 该技术为临时经静脉膈神经起搏,在择期房间隔缺损修补术前镇静机械通气患者中安全且有效辅助通气。

适用人群与场景

  • 24例镇静、机械通气的患者,均在择期房间隔缺损修补术前立即入组。
  • 1例因与装置无关的原因未能测试;1例因先天性左侧上腔静脉阻碍右侧捕获。

处置流程与药物剂量

  • 经Seldinger技术将9.5-Fr、含19个电极的中央静脉导管置入左锁骨下静脉及上腔静脉,评估最长90分钟。
  • 确定提供最佳经静脉右侧和左侧膈神经刺激的电极组合,并与机械通气呼吸同步激活。

研究设计与关键结果

  • 研究类型:首例人体病例系列;样本量24例;场景:血管造影室。
  • 23例完成全方案者中,经静脉刺激左侧膈神经捕获22/23(96%),右侧捕获20/23(87%)。
  • 1例因先天性左侧上腔静脉阻碍右侧捕获。
  • 22例起搏受试者刺激辅助呼吸期间呼吸机压力时间乘积均显著降低(范围9.9%–48.6%,p<0.001)。
  • 即刻及2周随访无不良事件。

证据类型、等级与局限

  • 证据类型:首例人体病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在该首例人体系列中,临时导管膈肌起搏安全且有效辅助机械通气。
  • 适用人群:择期房间隔缺损修补术前镇静、机械通气的患者。
  • 不适用人群:先天性左侧上腔静脉患者可能阻碍右侧捕获;原文有1例因此未能右侧捕获。
  • 常见陷阱:1例因与装置无关的原因未能测试,提示并非所有患者均可完成全方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Over 30% of critically ill patients on positive-pressure mechanical ventilation have difficulty weaning from the ventilator, many of whom acquire ventilator-induced diaphragm dysfunction. Temporary transvenous phrenic nerve pacing using a novel electrode-bearing catheter may provide a means to prevent diaphragm atrophy, to strengthen an atrophied diaphragm, and mitigate the harms of mechanical ventilation. We tested the initial safety, feasibility, and impact on ventilation of this novel approach.

DESIGN: First-in-Humans case series.

SETTING: Angiogram suite.

PATIENTS: Twenty-four sedated, mechanically ventilated patients immediately prior to an elective atrial septal defect repair procedure.

INTERVENTIONS: A 9.5-Fr central venous catheter with 19 embedded electrodes was placed via Seldinger technique into the left subclavian vein and superior vena cava and evaluated for up to 90 minutes. The electrode combinations determined to provide best transvenous stimulation of the right and left phrenic nerves were activated in synchrony with mechanically ventilated breaths.

MEASUREMENTS AND MAIN RESULTS: One patient could not be tested for reasons unrelated to the device. In the 23 patients who underwent the full protocol, transvenous stimulation activated the diaphragm in 22 of 23 (96%) left phrenic capture attempts and 20 of 23 (87%) right phrenic capture attempts. In one subject, a congenital left-sided superior vena cava precluded right-sided capture. Significant reductions in ventilator pressure-time-product were achieved during stimulation assisted breaths in all 22 paced subjects (range, 9.9-48.6%; p < 0.001). There were no adverse events either immediately or at 2-week follow-up.

CONCLUSIONS: In this First-in-Human series, diaphragm pacing with a temporary catheter was safe and effectively contributed to ventilation in conjunction with a mechanical ventilator.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Reynolds S, Ebner A, Meffen T, et al. Diaphragm Activation in Ventilated Patients Using a Novel Transvenous Phrenic Nerve Pacing Catheter. Crit Care Med. 2017. PMID: 28441238. doi:10.1097/CCM.0000000000002366

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。